Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $569.29M.
ENTERPRISE VALUE (EV)
$569.29M
Aquestive Therapeutics, Inc.
Market Cap
$563.35M
Enterprise Value (EV)
$569.29M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | $563.35M | $569.29M |
| CorMedix Inc. (CRMD)vs › | $563.90M | $452.36M |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $565.64M | $546.47M |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $572.90M | $500.89M |
| CytomX Therapeutics, Inc. (CTMX)vs › | $553.64M | $542.12M |
| OrthoPediatrics Corp. (KIDS)vs › | $585.02M | $659.61M |
| Delcath Systems, Inc. (DCTH)vs › | $537.16M | $492.10M |
| Crescent Biopharma, Inc. (CBIO)vs › | $530.42M | $360.26M |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $598.37M | $916.11M |
Market Cap
$563.35M
Total Debt
$127.11M
Cash
$121.17M
Enterprise Value
$569.29M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
